Bristol-Myers Exec faces up to a year in jail.

Andrew Bodnar, a former top executive at Bristol-Myers Squibb Co , faces up to a year in jail after pleading guilty to lying to federal officials about a deal to block a generic version of the company's top-selling medicine.

Bodnar, who was a senior vice president of strategy and a member of Bristol's executive committee, was indicted a year ago for misleading statements to the U.S. Federal Trade Commission about his dealings in 2006 with Canadian generic drugmaker Apotex Inc.

Story in NY Times.

Wonder when the New York Times will write about the criminal indictments against Pfizer execs and their Bextra related off-label crimes?